Erratum: Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life (Clinical Therapeutics, Volume 18, Number 3, 1996, page 508-518)

Clinical Therapeutics

Volumn 18, Issue 4, 1996, Pages 778-788

  Crucitt, M A ^a   Hyman, W ^a   Grote, T ^a   Tester, W ^a   Madajewicz, S ^a   Yee, S ^a   Wentz, A ^a   Griffin, D ^a   Parasuraman, T V ^a   Bryson, J ^a  

^a Box 9012   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERROR; REVIEW; ADULT; AGED; APPETITE; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; NEOPLASM; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ALKYLATING AGENT; ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; ONDANSETRON; PROCHLORPERAZINE;

ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; ANTINEOPLASTIC AGENTS, ALKYLATING; APPETITE; CYCLOPHOSPHAMIDE; DOUBLE-BLIND METHOD; HUMANS; NEOPLASMS; ONDANSETRON; PROCHLORPERAZINE; QUALITY OF LIFE; QUESTIONNAIRES; VOMITING;

EID: 0029770096     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80226-8     Document Type: Article

References (13)

1. LX Cubeddu IS Hoffmann NT Fuenmayor AL Finn Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting NEJM 22 1993 810 816
2. V Gebbia G Cannata A Testa Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting: Results of a prospective randomized trial Cancer 74 1994 1945 1952
3. TM Beck PJ Hesketh S Madajewicz Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting J Clin Oncol 10 1992 1969 1975
4. LX Cubeddu IS Hoffmann NT Fuenmayor AL Finn Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens J Clin Oncol 8 1990 1721 1727
5. TM Beck AA Ciociola SE Jones Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy Ann Intern Med 118 1993 407 413
6. TM Beck Efficacy of ondansetron tablets in the management of chemotherapy-induced emesis: Review of clinical trials Semin Oncol 19 1992 20 25 (Suppl 15)
7. J DiBenedetto L Cubeddu T Ryan Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy Clin Ther 17 1995 1091 1098
8. T Beck M York A Chang Oral ondansetron 8 mg BID is as effective as 8 mg TID in the prevention of nausea and vomiting associated with cyclophosphamide-based chemotherapy Proc Am Soc Clin Oncol 14 1995 538 Abstract
9. H Schipper J Clinch A McMurray M Levitt Measuring quality of life of cancer patients. The Functional Living Index—Cancer: Development and validation J Clin Oncol 2 1984 472 483
10. CM Lindley JD Hirsch CV O'Neill Quality of life consequences of chemotherapy-induced emesis Qual Life Res 1 1992 331 340
11. MA Dicato S Kaasa E Campora Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy-induced emesis: A randomized, single-blind, multicenter study Clin Oncol 4 1992 275 279
12. T Graves Emesis as a complication of cancer chemotherapy: Pathophysiology, importance, and treatment Pharmacotherapy 12 1992 337 345
13. MT Babowski Advances in anti-emetic therapy Cancer Treat Rev 11 1984 237 256